<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cAMP/PKA signalling events regulated by A-kinase anchoring proteins 10 (AKAP10) is involved in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Previous study showed that AKAP10 polymorphism (2073 A/G, I646V) was associated with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
<SENT sid="2" pm="."><plain>However, there was no literature reporting the role of AKAP10 in the pathogenesis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of the study was to investigate the clinicopathologic significance of A-kinase anchoring proteins 10 (AKAP 10) expression and the relationship with its polymorphism in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of AKAP10 was determined by immunohistochemical staining (IHC) and western blot assay on <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (n = 176), <z:mpath ids='MPATH_270'>adenoma</z:mpath> (n = 87) and distant <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (n = 72) </plain></SENT>
<SENT sid="5" pm="."><plain>176 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were genotyped for AKAP10 2073A/G polymorphism by TaqMan RT-PCR </plain></SENT>
<SENT sid="6" pm="."><plain>We found that the positive expression rate of AKAP10 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (59 %) was significantly higher than those in <z:mpath ids='MPATH_270'>adenoma</z:mpath> (39 %) and distant <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (42 %) (P = 0.004) </plain></SENT>
<SENT sid="7" pm="."><plain>There was no significant difference between <z:mpath ids='MPATH_270'>adenoma</z:mpath> and distant <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (P = 0.741) </plain></SENT>
<SENT sid="8" pm="."><plain>Positive AKAP10 staining was correlated with deeper <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion (P &lt; 0.001), lymph nodes <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P = 0.022), advanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage (P &lt; 0.001) and poorly differentiated degree (P = 0.003) </plain></SENT>
<SENT sid="9" pm="."><plain>Compared with AA genotype (52 %), positive expression of AKAP10 was significantly increased in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients with the variant (AG+GG) genotypes (68 %, P = 0.033) </plain></SENT>
<SENT sid="10" pm="."><plain>It was concluded that AKAP10 may play an important role in the development and progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>